A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With or Without Decreased Arousal)
Clinical trial NCT04943068 · COMPLETED
Trial details
- NCT number
- NCT04943068
- Sponsor
- Kwang Dong Pharmaceutical co., ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-10
- Primary completion
- 2023-05-16
- Enrollment
- 193
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.